DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 11:54:17 GMT 2023` Edited by `admin` on `Sat Dec 16 11:54:17 GMT 2023`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	CTZ3P20I6M
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1

Common Name

English

MEK-1

Common Name

English

MEK 1

Common Name

English

MAPKK 1

Common Name

English

MAP KINASE KINASE 1

Common Name

English

MKK1

Common Name

English

ERK ACTIVATOR KINASE 1

Common Name

English

PRKMK1

Common Name

English

MEK1

Common Name

English

MAPK/ERK KINASE 1

Common Name

English

Code System Code Type Description

FDA UNII

CTZ3P20I6M

Created by admin on Sat Dec 16 11:54:18 GMT 2023 , Edited by admin on Sat Dec 16 11:54:18 GMT 2023

PRIMARY

WIKIPEDIA

MAP2K1

Created by admin on Sat Dec 16 11:54:18 GMT 2023 , Edited by admin on Sat Dec 16 11:54:18 GMT 2023

PRIMARY

PHAROS

Q02750

Created by admin on Sat Dec 16 11:54:18 GMT 2023 , Edited by admin on Sat Dec 16 11:54:18 GMT 2023

PRIMARY

UNIPROT

Q02750

Created by admin on Sat Dec 16 11:54:18 GMT 2023 , Edited by admin on Sat Dec 16 11:54:18 GMT 2023

PRIMARY

Related Record Type Details


					6UH91I579U

SELUMETINIB

INHIBITOR -> TARGET

Comments:

Incorporation of [J33P]phosphate from [J33P]ATP into ERK2

Interaction Type:

UNCOMPETITIVE

Qualification:

IC50

Amount:


					4RZD8LK83V

Zapnometinib

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					5J61HSP0QJ

TAK-733

INHIBITOR -> TARGET


					K5T4I78IYZ

Nedometinib

INHIBITOR -> TARGET

Amount:


					JPX07AFM0N

REFAMETINIB

INHIBITOR -> TARGET

Amount:


					RM3RX36H4Y

6-(4-BROMO-2-FLUORO-ANILINO)-7-FLUORO-N-(2-HYDROXYETHOXY)-3H-BENZIMIDAZOLE-5-CARBOXAMIDE

INHIBITOR -> TARGET

Amount:


					R3K9Y00J04

CI-1040

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					181R97MR71

Binimetinib

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					14FDK6ISC9

ASTX-029

INHIBITOR -> TARGET


					16ZDH50O1U

ULIXERTINIB

INHIBITOR -> TARGET

Interaction Type:

REVERSIBLE

Qualification:

Ki

Amount:


					M58JOZ0T53

RO-5068760

INHIBITOR -> TARGET


					D0D4252V97

Avutometinib

INHIBITOR -> TARGET

Amount:


					86K0J5AK6M

MIRDAMETINIB

INHIBITOR -> TARGET


					8027P94HLL

U-0126

INHIBITOR -> TARGET


					33E86K87QN

TRAMETINIB

INHIBITOR -> TARGET


					ER29L26N1X

COBIMETINIB

INHIBITOR -> TARGET

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL